{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:28:59Z","timestamp":1790998139169,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jdcr.2020.04.036","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T23:20:59Z","timestamp":1589152859000},"page":"675-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"Stephanie R.","family":"Jackson Cullison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw J.","family":"Jedrych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaina J.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2020.04.036_bib1","author":"Haas"},{"key":"10.1016\/j.jdcr.2020.04.036_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12889-015-1867-2","article-title":"Intervenable factors associated with suicide risk in transgender persons: a respondent driven sampling study in Ontario, Canada","volume":"15","author":"Bauer","year":"2015","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.jdcr.2020.04.036_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2019.03.023","article-title":"Issues in transgender dermatology: a systematic review of the literature","volume":"81","author":"Sullivan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2020.04.036_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ecl.2019.01.005","article-title":"Dermatologic conditions in transgender populations","volume":"48","author":"Yeung","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.jdcr.2020.04.036_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijwd.2018.08.008","article-title":"Medical dermatologic conditions in transgender women","volume":"4","author":"Mundluru","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.jdcr.2020.04.036_bib6","series-title":"Dermatology","year":"2012"},{"issue":"9","key":"10.1016\/j.jdcr.2020.04.036_bib7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdcr.2020.04.036_bib8","author":"Deutsch"},{"issue":"2","key":"10.1016\/j.jdcr.2020.04.036_bib9","first-page":"e11","article-title":"A case of hypopituitarism and porphyria cutanea tarda in relation to estrogen therapy in a patient with empty sella syndrome","volume":"215","author":"Modrono Mostoles","year":"2015","journal-title":"Rev Clin Esp"},{"issue":"1","key":"10.1016\/j.jdcr.2020.04.036_bib10","doi-asserted-by":"crossref","first-page":"30380","DOI":"10.3402\/jchimp.v6.30380","article-title":"Porphyria cutanea tarda associated with HFE C282Y homozygosity, iron overload, and use of a contraceptive vaginal ring","volume":"6","author":"Barton","year":"2016","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"1","key":"10.1016\/j.jdcr.2020.04.036_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/trgh.2017.0025","article-title":"Advocacy for gender affirming care: learning from the injectable estrogen shortage","volume":"3","author":"Geffen","year":"2018","journal-title":"Transgend Health"},{"key":"10.1016\/j.jdcr.2020.04.036_bib12","series-title":"Injustice at every turn: a report of the national transgender discrimination survey","author":"Grant","year":"2011"},{"key":"10.1016\/j.jdcr.2020.04.036_bib13","author":"Powers"},{"key":"10.1016\/j.jdcr.2020.04.036_bib14","series-title":"Standards of care for the health of transsexual, transgender, and gender nonconforming people","author":"Coleman","year":"2012"},{"issue":"11","key":"10.1016\/j.jdcr.2020.04.036_bib15","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society Clinical Practice Guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jdcr.2020.04.036_bib16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/jamainternmed.2018.4179","article-title":"Acute clinical care for transgender patients: a review","volume":"178","author":"Rosendale","year":"2018","journal-title":"JAMA Intern Med"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620303295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620303295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:21:59Z","timestamp":1762474919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512620303295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2352512620303295"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.04.036","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}